Clinical Trial Update: A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating neoadjuvant targeted therapy, immunotherapy, and lysogenic HSV-based virotherapy in patients with resectable head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Immunotherapy (neoadjuvant)
• Lysogenic HSV-based virotherapy
• Targeted therapy (neoadjuvant)

Snippet

Sponsor: West China Hospital | Conditions: HNSCC, Lysogenic HSV Virus | Phase 1, Phase 2 | Status: RECRUITING